Palm Valley Capital Management, an investment management firm, has issued the first-quarter 2026 investor letter for the ...
Teleflex has recently overhauled its governance, naming long-time director Andrew A. Krakauer as Chairman, adding Michael J. Tokich to the Board, forming a new Growth and Operating Committee, and ...
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...
Over the last six months, Teleflex’s shares have sunk to $113.26, producing a disappointing 13% loss - a stark contrast to ...
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their ...
Fintel on MSN
Raymond James upgrades Teleflex (TFX)
Fintel reports that on March 27, 2026, Raymond James upgraded their outlook for Teleflex (NYSE:TFX) from Market Perform to Outperform. Analyst Price Forecast Suggests 18.69% Upside As of February 24, ...
Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, ...
The stock price of Teleflex, best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a decline of 12% over the last month, while it was down over 4% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results